Targeted delivery of miR-34a-5p by phenylborate-coupled polyethylenimide nanocarriers for anti-KSHV treatment
Kaposi’s sarcoma-associated herpesvirus (KSHV) can infect a variety of cells and cause malignant tumors. At present, the use of microRNA (miRNA) for anti-KSHV is a promising treatment strategy, but the instability and non-specific uptake of miRNA still limit its use in the treatment of KSHV. In the...
Main Authors: | Fangling Li, Dongdong Cao, Lixia Yao, Wenyi Gu, Zhiyong Liu, Dongmei Li, Lin Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1343956/full |
Similar Items
-
Folate-Targeted Nanocarriers Co-Deliver Ganciclovir and miR-34a-5p for Combined Anti-KSHV Therapy
by: Fangling Li, et al.
Published: (2024-03-01) -
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
by: Kinga Piorecka, et al.
Published: (2021-08-01) -
The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers
by: Ashley Markazi, et al.
Published: (2021-08-01) -
SUMO and KSHV Replication
by: Pei-Ching Chang, et al.
Published: (2014-09-01) -
KSHV genome replication and maintenance
by: Pravinkumar ePurushothaman, et al.
Published: (2016-02-01)